October 2, 2025

Supplementary figure 3 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma

View Full Paper

Ask AI

Bookmark

Nrf2 hyperactivation contributes to resistance against radiotherapy, limiting treatment success.
The study highlights that the influence of Keap1 status and tobacco carcinogens complicates tumor response.
Observational analysis reveals a relationship between nrf2 activation and suppressed antitumor immune responses.
Understanding these mechanisms may enable the development of more effective therapeutic strategies.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

This analysis reveals that nrf2 activation reduces antitumor immunity in head and neck squamous cell carcinoma, suggesting implications for treatment.

Abstract

Primary tumor growth influenced by Keap1 status and tobacco carcinogen, BAP

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Patel et al. (2025) studied this question.

synapsesocial.com/papers/68de68f183cbc991d0a21b18 https://doi.org/10.1158/1078-0432.30254924

View Full Paper

Ask AI

Bookmark

Implication

This analysis reveals that nrf2 activation reduces antitumor immunity in head and neck squamous cell carcinoma, suggesting implications for treatment.

Abstract

Primary tumor growth influenced by Keap1 status and tobacco carcinogen, BAP

Supplementary figure 3 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma

Key Points

No abstract yet

Implication

Abstract

Discussion

Cite This Study

Supplementary figure 3 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma

Key Points

No abstract yet

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading